>> Should the reo prove effective even only in injectable non-metastised cancer, that already would be a major improvement over surgery, I'd think. <<
For a cancer that has not metastasized and which has not invaded something critical, surgery will be the preferred therapy for decades, if not until "the end of time". It is 100% curative. Why muck with anything else?
I guess, over time, enough experience could be obtained with the injection of inoperable primaries, such that the risk with operable cancers would be known to approach zero. But there's a difference between talking "experimental protocol" and "good investment". BioTransplant's AlloMune is a fascinating experimental protocol.
Look, I've cured (a strong word, but, since the tumors didn't metastasize, it's applicable) about a zillion rats and mice with fibrosarcomas that would have otherwise been fatal. But I've never encountered real world disease, and I'm outta my league here. I'll leave further comment to any oncologists who might drop in. |
